Literature DB >> 8772585

Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis.

J F Tseng1, I P Ryan, T D Milam, J T Murai, E D Schriock, D V Landers, R N Taylor.   

Abstract

An in vitro model developed to compare human endometrial and endometriosis stromal cells was used to examine basal and stimulated expression of interleukin (IL-6). Stromal cells isolated from normal endometrium (NE) exhibited the lowest level of IL-6 secretion (84 pg/10(6) cells-48 h), whereas those cells isolated from endometriosis implants (EI) secreted the highest concentration of this inflammatory cytokine (46,284 pg/10(5) cells-48 h; P < 0.01). Eutopic endometrial stromal cells from women with endometriosis (EE) expressed an intermediate concentration of IL-6 (831 pg/10(6) cells-48 h). Stimulation of the various cultures with IL-1 beta dramatically augmented stromal cell production of IL-6. The mean concentrations of stimulated IL-6 secretion were 16,257, 37,800, and 264,290 pg/10(5) cells-48 h for NE, EE, and EI cells, respectively (P < 0.03). Exposure of the cell cultures to 10 nmol/L estradiol had little direct effect on IL-6 production. The results indicate that endometrial stromal cells isolated from tissues of women with and without endometriosis express IL-6 under basal and cytokine-stimulated conditions. Differential responsiveness among the three cell sources indicates that NE, EE, and EI cells have intrinsic quantitative differences in cytokine regulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772585     DOI: 10.1210/jcem.81.3.8772585

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  50 in total

1.  Glycosylation and over-expression of endometriosis-associated peritoneal haptoglobin.

Authors:  Marta Piva; J Ignacio Moreno; Kathy L Sharpe-Timms
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

2.  Polymorphisms for interleukin-1 beta (IL-1 beta)-511 promoter, IL-1 beta exon 5, and IL-1 receptor antagonist: nonassociation with endometriosis.

Authors:  Y Y Hsieh; C C Chang; F J Tsai; J Y Wu; Y R Shi; H D Tsai; C H Tsai
Journal:  J Assist Reprod Genet       Date:  2001-09       Impact factor: 3.412

3.  Low follicular fluid IL-6 levels in IVF patients are associated with increased likelihood of clinical pregnancy.

Authors:  Tugba Altun; Sangita Jindal; Keri Greenseid; Jun Shu; Lubna Pal
Journal:  J Assist Reprod Genet       Date:  2010-11-03       Impact factor: 3.412

Review 4.  Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways.

Authors:  Robert N Taylor; Maureen A Kane; Neil Sidell
Journal:  Semin Reprod Med       Date:  2015-07-01       Impact factor: 1.303

5.  Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis.

Authors:  A Akoum; C Jolicoeur; A Kharfi; M Aubé
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 6.  Pathogenesis and pathophysiology of endometriosis.

Authors:  Richard O Burney; Linda C Giudice
Journal:  Fertil Steril       Date:  2012-07-20       Impact factor: 7.329

Review 7.  The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis.

Authors:  Sang Jun Han; Bert W O'Malley
Journal:  Hum Reprod Update       Date:  2014-03-14       Impact factor: 15.610

8.  IL-1β Stimulates Brain-Derived Neurotrophic Factor Production in Eutopic Endometriosis Stromal Cell Cultures: A Model for Cytokine Regulation of Neuroangiogenesis.

Authors:  Jie Yu; Antônio M C Francisco; Bansari G Patel; J Mark Cline; Eric Zou; Sarah L Berga; Robert N Taylor
Journal:  Am J Pathol       Date:  2018-07-20       Impact factor: 4.307

Review 9.  The role of lipoxin A4 in endometrial biology and endometriosis.

Authors:  G O Canny; B A Lessey
Journal:  Mucosal Immunol       Date:  2013-03-13       Impact factor: 7.313

10.  The pathophysiology of endometriosis and adenomyosis: tissue injury and repair.

Authors:  G Leyendecker; L Wildt; G Mall
Journal:  Arch Gynecol Obstet       Date:  2009-07-31       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.